Thyrocare Technologies Limited (BSE:539871) entered into business transfer agreement to acquire Diagnostic and pathological services business of Polo Labs Private Limited from Polo Labs Private Limited for INR 42.6 million on July 2, 2024. The transaction is expected to complete 60 business days from the execution date of the business transfer agreement .
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
644.1 INR | -0.11% | +1.57% | +0.09% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.09% | 41Cr | |
-18.64% | 845.66Cr | |
+71.50% | 440.55Cr | |
+11.92% | 287.54Cr | |
-2.80% | 264.1Cr | |
-16.07% | 173.43Cr | |
-57.49% | 170.08Cr | |
-16.46% | 150.08Cr | |
-49.06% | 103.37Cr | |
+16.62% | 97Cr |
- Stock Market
- Equities
- THYROCARE Stock
- News Thyrocare Technologies Limited
- Thyrocare Technologies Limited entered into business transfer agreement to acquire Diagnostic and pathological services business of Polo Labs Private Limited from Polo Labs Private Limited for INR 42.6 million.